GLP ‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials
Aims
To assess if there is a difference in the oncogenic risk between GLP‐1 RA and comparators in randomized controlled trials.
Materials and Methods
A meta‐analysis of randomized controlled trials comparing GLP‐1RA to any comparators for diabetes and/or obesity, lasting at least 52 weeks. The endpoints included the incidence of overall cancers and single malignancies.
Results
Fifty trials were included. GLP‐1RA treatment was not associated with a significant difference in risk for overall cancer (MH‐OR 1.05, 95% confidence interval [CI] [0.98, 1.13]). Uterine cancer was significantly reduced in the GLP‐1RA arm in trials performed in subjects with obesity (MH‐OR 0.24, 95% CI [0.06, 0.94]), but not in those aimed at diabetes treatment (MH‐OR 0.92, [0.58, 1.47]). We detected an increase in the risk for thyroid cancer (MH‐OR 1.55, [1.05, 2.27]), more evident in longer‐term trials, and in the risk for colorectal cancer (MH‐OR 1.27 [1.03, 1.57]), which, conversely, was significant only in shorter‐term trials. No significant difference in the risk was detected for any other cancer.
Conclusions
GLP‐1 RA do not appear to produce an effect on most malignancies in clinical trials. A reduction of very close obesity‐associated cancers seems possible, whereas a risk signal for thyroid cancer was observed, prompting the need for further specific studies. On the other hand, the small increase observed in colorectal cancer in shorter‐term trials may be the effect of a disproportionate increase in diagnostic procedures in the GLP‐1 RA arm, because of the suspicion raised by common side effects of GLP‐1 RA.
No keywords indexed for this article. Browse by subject →
Eugenia E. Calle, Rudolf Kaaks
Mihaela-Simona Popoviciu, Lorena Păduraru, Galal Yahya et al.
A. Michael Lincoff, Kirstine Brown-Frandsen, Helen M. Colhoun et al.
Jonathan A C Sterne, Jelena Savović, Matthew J Page et al.
Showing 50 of 103 references
- Published
- May 29, 2025
- Vol/Issue
- 27(8)
- Pages
- 4454-4468
- License
- View
You May Also Like
John P. H. Wilding, Rachel L. Batterham · 2022
798 citations
Michael A Nauck, Juris J. Meier · 2018
738 citations
P. Ferré, F. Foufelle · 2010
608 citations
R. Grempler, L. Thomas · 2011
509 citations
David Russell‐Jones, Rehman Khan · 2006
454 citations